Molecular mechanics and dynamic simulations of well-known Kabuki syndrome-associated KDM6A variants reveal putative mechanisms of dysfunction.
Epigenetic regulators
Genomic variation
Histone demethylase
KDM6A
Kabuki syndrome
Molecular dynamics
Mutational impact analysis
Protein structure
Journal
Orphanet journal of rare diseases
ISSN: 1750-1172
Titre abrégé: Orphanet J Rare Dis
Pays: England
ID NLM: 101266602
Informations de publication
Date de publication:
05 02 2021
05 02 2021
Historique:
received:
04
11
2020
accepted:
15
01
2021
entrez:
6
2
2021
pubmed:
7
2
2021
medline:
22
6
2021
Statut:
epublish
Résumé
Kabuki syndrome is a genetic disorder that affects several body systems and presents with variations in symptoms and severity. The syndrome is named for a common phenotype of faces resembling stage makeup used in a Japanese traditional theatrical art named kabuki. The most frequent cause of this syndrome is mutations in the H3K4 family of histone methyltransferases while a smaller percentage results from genetic alterations affecting the histone demethylase, KDM6A. Because of the rare presentation of the latter form of the disease, little is known about how missense changes in the KDM6A protein sequence impact protein function. In this study, we use molecular mechanic and molecular dynamic simulations to enhance the annotation and mechanistic interpretation of the potential impact of eleven KDM6A missense variants found in Kabuki syndrome patients. These variants (N910S, D980V, S1025G, C1153R, C1153Y, P1195L, L1200F, Q1212R, Q1248R, R1255W, and R1351Q) are predicted to be pathogenic, likely pathogenic or of uncertain significance by sequence-based analysis. Here, we demonstrate, for the first time, that although Kabuki syndrome missense variants are found outside the functionally critical regions, they could affect overall function by significantly disrupting global and local conformation (C1153R, C1153Y, P1195L, L1200F, Q1212R, Q1248R, R1255W and R1351Q), chemical environment (C1153R, C1153Y, P1195L, L1200F, Q1212R, Q1248R, R1255W and R1351Q), and/or molecular dynamics of the catalytic domain (all variants). In addition, our approaches predict that many mutations, in particular C1153R, could allosterically disrupt the key enzymatic interactions of KDM6A. Our study demonstrates that the KDM6A Kabuki syndrome variants may impair histone demethylase function through various mechanisms that include altered protein integrity, local environment, molecular interactions and protein dynamics. Molecular dynamics simulations of the wild type and the variants are critical to gain a better understanding of molecular dysfunction. This type of comprehensive structure- and MD-based analyses should help develop improved impact scoring systems to interpret the damaging effects of variants in this protein and other related proteins as well as provide detailed mechanistic insight that is not currently predictable from sequence alone.
Sections du résumé
BACKGROUND
Kabuki syndrome is a genetic disorder that affects several body systems and presents with variations in symptoms and severity. The syndrome is named for a common phenotype of faces resembling stage makeup used in a Japanese traditional theatrical art named kabuki. The most frequent cause of this syndrome is mutations in the H3K4 family of histone methyltransferases while a smaller percentage results from genetic alterations affecting the histone demethylase, KDM6A. Because of the rare presentation of the latter form of the disease, little is known about how missense changes in the KDM6A protein sequence impact protein function.
RESULTS
In this study, we use molecular mechanic and molecular dynamic simulations to enhance the annotation and mechanistic interpretation of the potential impact of eleven KDM6A missense variants found in Kabuki syndrome patients. These variants (N910S, D980V, S1025G, C1153R, C1153Y, P1195L, L1200F, Q1212R, Q1248R, R1255W, and R1351Q) are predicted to be pathogenic, likely pathogenic or of uncertain significance by sequence-based analysis. Here, we demonstrate, for the first time, that although Kabuki syndrome missense variants are found outside the functionally critical regions, they could affect overall function by significantly disrupting global and local conformation (C1153R, C1153Y, P1195L, L1200F, Q1212R, Q1248R, R1255W and R1351Q), chemical environment (C1153R, C1153Y, P1195L, L1200F, Q1212R, Q1248R, R1255W and R1351Q), and/or molecular dynamics of the catalytic domain (all variants). In addition, our approaches predict that many mutations, in particular C1153R, could allosterically disrupt the key enzymatic interactions of KDM6A.
CONCLUSIONS
Our study demonstrates that the KDM6A Kabuki syndrome variants may impair histone demethylase function through various mechanisms that include altered protein integrity, local environment, molecular interactions and protein dynamics. Molecular dynamics simulations of the wild type and the variants are critical to gain a better understanding of molecular dysfunction. This type of comprehensive structure- and MD-based analyses should help develop improved impact scoring systems to interpret the damaging effects of variants in this protein and other related proteins as well as provide detailed mechanistic insight that is not currently predictable from sequence alone.
Identifiants
pubmed: 33546721
doi: 10.1186/s13023-021-01692-w
pii: 10.1186/s13023-021-01692-w
pmc: PMC7866879
doi:
Substances chimiques
Histone Demethylases
EC 1.14.11.-
KDM6A protein, human
EC 1.14.11.-
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
66Subventions
Organisme : NCI NIH HHS
ID : R01 CA178627
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK052913
Pays : United States
Organisme : NIGMS NIH HHS
ID : R35 GM128840
Pays : United States
Organisme : National Intitute of Diabetes and Digestive and Kidney Diseases
ID : R01DK052913
Organisme : NCI NIH HHS
ID : R01 CA247898
Pays : United States
Commentaires et corrections
Type : ErratumIn
Références
Zimmermann MT, Urrutia R, Cousin MA, Oliver GR, Klee EW. Assessing human genetic variations in glucose transporter SLC2A10 and THEIR ROLE IN ALTERING STRUCTURAL AND FUNCTIONAL PROPERTIES. Front Genet. 2018;9:276.
pubmed: 30090112
pmcid: 6068234
Gupta A, Dsouza NR, Zarate YA, Lombardo R, Hopkin R, Linehan AR, et al. Genetic variants in DGAT1 cause diverse clinical presentations of malnutrition through a specific molecular mechanism. Eur J Med Genet. 2020;63(4):103817.
pubmed: 31778854
Kaiwar C, Zimmermann MT, Ferber MJ, Niu Z, Urrutia RA, Klee EW, et al. Novel NR2F1 variants likely disrupt DNA binding: molecular modeling in two cases, review of published cases, genotype-phenotype correlation, and phenotypic expansion of the Bosch-Boonstra-Schaaf optic atrophy syndrome. Cold Spring Harb Mol Case Stud. 2017;3(6):a002162.
pubmed: 28963436
pmcid: 5701304
Cousin MA, Zimmermann MT, Mathison AJ, Blackburn PR, Boczek NJ, Oliver GR, et al. Functional validation reveals the novel missense V419L variant in TGFBR2 associated with Loeys-Dietz syndrome (LDS) impairs canonical TGF-beta signaling. Cold Spring Harb Mol Case Stud. 2017;3(4):a001727.
pubmed: 28679693
pmcid: 5495030
Swigut T, Wysocka J. H3K27 demethylases, at long last. Cell. 2007;131(1):29–32.
pubmed: 17923085
Gazova I, Lengeling A, Summers KM. Lysine demethylases KDM6A and UTY: The X and Y of histone demethylation. Mol Genet Metab. 2019;127(1):31–44.
pubmed: 31097364
Islam MS, Leissing TM, Chowdhury R, Hopkinson RJ, Schofield CJ. 2-oxoglutarate-dependent oxygenases. Annu Rev Biochem. 2018;87:585–620.
pubmed: 29494239
Lee S, Lee JW, Lee SK. UTX, a histone H3-lysine 27 demethylase, acts as a critical switch to activate the cardiac developmental program. Dev Cell. 2012;22(1):25–37.
pubmed: 22192413
Hemming S, Cakouros D, Isenmann S, Cooper L, Menicanin D, Zannettino A, et al. EZH2 and KDM6A act as an epigenetic switch to regulate mesenchymal stem cell lineage specification. Stem Cells. 2014;32(3):802–15.
pubmed: 24123378
Welstead GG, Creyghton MP, Bilodeau S, Cheng AW, Markoulaki S, Young RA, et al. X-linked H3K27me3 demethylase Utx is required for embryonic development in a sex-specific manner. Proc Natl Acad Sci U S A. 2012;109(32):13004–9.
pubmed: 22826230
pmcid: 3420177
Thieme S, Gyarfas T, Richter C, Ozhan G, Fu J, Alexopoulou D, et al. The histone demethylase UTX regulates stem cell migration and hematopoiesis. Blood. 2013;121(13):2462–73.
pubmed: 23365460
Banka S, Lederer D, Benoit V, Jenkins E, Howard E, Bunstone S, et al. Novel KDM6A (UTX) mutations and a clinical and molecular review of the X-linked Kabuki syndrome (KS2). Clin Genet. 2015;87(3):252–8.
pubmed: 24527667
Bogershausen N, Gatinois V, Riehmer V, Kayserili H, Becker J, Thoenes M, et al. Mutation Update for Kabuki Syndrome Genes KMT2D and KDM6A and further delineation of X-linked kabuki syndrome subtype 2. Hum Mutat. 2016;37(9):847–64.
pubmed: 27302555
Miyake N, Koshimizu E, Okamoto N, Mizuno S, Ogata T, Nagai T, et al. MLL2 and KDM6A mutations in patients with Kabuki syndrome. Am J Med Genet A. 2013;161A(9):2234–43.
pubmed: 23913813
Stagi S, Gulino AV, Lapi E, Rigante D. Epigenetic control of the immune system: a lesson from Kabuki syndrome. Immunol Res. 2016;64(2):345–59.
pubmed: 26411453
Hu Z, Yu C, Furutsuki M, Andreoletti G, Ly M, Hoskins R, et al. VIPdb, a genetic variant impact predictor database. Hum Mutat. 2019;40(9):1202–14.
pubmed: 31283070
pmcid: 7288905
Vaser R, Adusumalli S, Leng SN, Sikic M, Ng PC. SIFT missense predictions for genomes. Nat Protoc. 2016;11(1):1–9.
pubmed: 26633127
Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7(4):248–9.
pubmed: 20354512
pmcid: 2855889
Ittisoponpisan S, Islam SA, Khanna T, Alhuzimi E, David A, Sternberg MJE. Can predicted protein 3D structures provide reliable insights into whether missense variants are disease associated? J Mol Biol. 2019;431(11):2197–212.
pubmed: 30995449
pmcid: 6544567
Ponzoni L, Bahar I. Structural dynamics is a determinant of the functional significance of missense variants. Proc Natl Acad Sci U S A. 2018;115(16):4164–9.
pubmed: 29610305
pmcid: 5910821
Sengoku T, Yokoyama S. Structural basis for histone H3 Lys 27 demethylation by UTX/KDM6A. Genes Dev. 2011;25(21):2266–77.
pubmed: 22002947
pmcid: 3219231
Stenson PD, Ball EV, Mort M, Phillips AD, Shiel JA, Thomas NS, et al. Human Gene Mutation Database (HGMD): 2003 update. Hum Mutat. 2003;21(6):577–81.
pubmed: 12754702
Landrum MJ, Lee JM, Riley GR, Jang W, Rubinstein WS, Church DM, et al. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res. 2014;42(Database issue):D980–5.
Cocciadiferro D, Augello B, De Nittis P, Zhang J, Mandriani B, Malerba N, et al. Dissecting KMT2D missense mutations in Kabuki syndrome patients. Hum Mol Genet. 2018;27(21):3651–68.
pubmed: 30107592
pmcid: 6488975
Lee MG, Villa R, Trojer P, Norman J, Yan KP, Reinberg D, et al. Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination. Science. 2007;318(5849):447–50.
pubmed: 17761849
Hong S, Cho YW, Yu LR, Yu H, Veenstra TD, Ge K. Identification of JmjC domain-containing UTX and JMJD3 as histone H3 lysine 27 demethylases. Proc Natl Acad Sci U S A. 2007;104(47):18439–44.
pubmed: 18003914
pmcid: 2141795
Ponzoni L, Penaherrera DA, Oltvai ZN, Bahar I. Rhapsody: Predicting the pathogenicity of human missense variants. Bioinformatics. 2020.
Ancien F, Pucci F, Godfroid M, Rooman M. Prediction and interpretation of deleterious coding variants in terms of protein structural stability. Sci Rep. 2018;8(1):4480.
pubmed: 29540703
pmcid: 5852127
Strokach A, Corbi-Verge C, Teyra J, Kim PM. Predicting the effect of mutations on protein folding and protein-protein interactions. Methods Mol Biol. 2019;1851:1–17.
pubmed: 30298389
Guerois R, Nielsen JE, Serrano L. Predicting changes in the stability of proteins and protein complexes: a study of more than 1000 mutations. J Mol Biol. 2002;320(2):369–87.
pubmed: 12079393
Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr. 2004;60(Pt 12 Pt 1):2126–32.
pubmed: 15572765
Gaweska H, Henderson Pozzi M, Schmidt DM, McCafferty DG, Fitzpatrick PF. Use of pH and kinetic isotope effects to establish chemistry as rate-limiting in oxidation of a peptide substrate by LSD1. Biochemistry. 2009;48(23):5440–5.
pubmed: 19408960
Chakraborty AA, Laukka T, Myllykoski M, Ringel AE, Booker MA, Tolstorukov MY, et al. Histone demethylase KDM6A directly senses oxygen to control chromatin and cell fate. Science. 2019;363(6432):1217–22.
pubmed: 30872525
pmcid: 7336390
Wang L, Zhang M, Alexov E. DelPhiPKa web server: predicting pKa of proteins. RNAs and DNAs Bioinf. 2016;32(4):614–5.
Wang L, Shilatifard A. UTX mutations in human cancer. Cancer Cell. 2019;35(2):168–76.
pubmed: 30753822
pmcid: 6589339
Schulz WA, Lang A, Koch J, Greife A. The histone demethylase UTX/KDM6A in cancer: Progress and puzzles. Int J Cancer. 2019;145(3):614–20.
pubmed: 30628063
Dulak AM, Stojanov P, Peng S, Lawrence MS, Fox C, Stewart C, et al. Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity. Nat Genet. 2013;45(5):478–86.
pubmed: 23525077
pmcid: 3678719
Shah SP, Roth A, Goya R, Oloumi A, Ha G, Zhao Y, et al. The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature. 2012;486(7403):395–9.
Zehir A, Benayed R, Shah RH, Syed A, Middha S, Kim HR, et al. Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nat Med. 2017;23(6):703–13.
pubmed: 28481359
pmcid: 5461196
Palsgrove DN, Brosnan-Cashman JA, Giannini C, Raghunathan A, Jentoft M, Bettegowda C, et al. Subependymal giant cell astrocytoma-like astrocytoma: a neoplasm with a distinct phenotype and frequent neurofibromatosis type-1-association. Mod Pathol. 2018;31(12):1787–800.
pubmed: 29973652
pmcid: 6269209
Walport LJ, Hopkinson RJ, Vollmar M, Madden SK, Gileadi C, Oppermann U, et al. Human UTY(KDM6C) is a male-specific N-methyl lysyl demethylase. J Biol Chem. 2014;289(26):18302–13.
pubmed: 24798337
pmcid: 4140284
Masso M. All-atom four-body knowledge-based statistical potentials to distinguish native protein structures from nonnative folds. Biomed Res Int. 2017;2017:5760612.
pubmed: 29119109
pmcid: 5651141
Jenik M, Parra RG, Radusky LG, Turjanski A, Wolynes PG, Ferreiro DU. Protein frustratometer: a tool to localize energetic frustration in protein molecules. Nucleic Acids Res. 2012;40(Web Server issue):W348–51.
Seton-Rogers S. Pancreatic cancer: the COMPASS shows the way. Nat Rev Cancer. 2018;18(5):373.
pubmed: 29610488
Cho YW, Hong T, Hong S, Guo H, Yu H, Kim D, et al. PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex. J Biol Chem. 2007;282(28):20395–406.
pubmed: 17500065
Webb B, Sali A. Protein structure modeling with MODELLER. Methods Mol Biol. 2017;1654:39–54.
pubmed: 28986782
Tang H, Thomas PD. Tools for predicting the functional impact of nonsynonymous genetic variation. Genetics. 2016;203(2):635–47.
pubmed: 27270698
pmcid: 4896183
Grant BJ, Rodrigues AP, ElSawy KM, McCammon JA, Caves LS. Bio3d: an R package for the comparative analysis of protein structures. Bioinformatics. 2006;22(21):2695–6.
pubmed: 16940322